Location History:
- Binningen, CH (2014)
- Eiken, CH (2017)
- Laufenburg, CH (2021 - 2024)
Company Filing History:
10 out of 22 
1 out of 284 
Years Active: 2014-2025
Title: The Innovative Contributions of Marc Gitzinger
Introduction
Marc Gitzinger is a notable inventor based in Binningen, Switzerland. He has made significant contributions to the field of medicine, particularly in the development of antibiotic treatments. With a total of 12 patents to his name, Gitzinger's work has had a profound impact on the treatment of bacterial infections.
Latest Patents
Among his latest patents, Gitzinger has developed formulations for rifabutin treatment methods, uses, and compositions. This invention provides formulations containing highly concentrated solutions of rifabutin and methods for making such formulations. Additionally, he has created methods for using these formulations to treat bacterial infections in subjects. Another significant patent involves antibiotic combination therapies, which provide innovative solutions for treating infections. These combination therapies include rifabutin and a second antibiotic, such as colistin and cefiderocol.
Career Highlights
Throughout his career, Marc Gitzinger has worked with prominent organizations, including Bioversys AG and ETH Zurich. His experience in these institutions has allowed him to advance his research and contribute to the development of effective medical treatments.
Collaborations
Gitzinger has collaborated with several professionals in his field, including Glenn E. Dale and Sergio Lociuro. These partnerships have facilitated the exchange of ideas and fostered innovation in antibiotic therapies.
Conclusion
Marc Gitzinger's contributions to the field of medicine through his innovative patents and collaborations highlight his dedication to improving treatment options for bacterial infections. His work continues to influence the medical community and pave the way for future advancements.